Dexa Group
Awards Earned
Primaniyarta
Award
Ministry
of Trade
of Trade
2005 • 2017-2019 • 2021
Indonesia's Most
Admired Companies
Warta
Ekonomi
Ekonomi
2017-2019
Top Brand
for Kids
Marketing
Magazine
Magazine
2009-2020 • 2022
Outstanding Corporate
Innovator
Product Development and
Management Association
Management Association
2018
IIRDI
Award
Ministry of Research
and Technology
and Technology
2018-2019
BPOM
Award
Food and Drug
Agency Indonesia
Agency Indonesia
2017
Dexa means Quality
Our name was inspired by the Greek δέκα, meaning 10 — a universal symbol of perfection. Even today, our work aspires to that same impossible standard. That’s why, for millions of people in 14 countries, Dexa means quality.
Our Companies
Indonesian Modern Herbal Medicines
We identify, extract, and test biomolecules embedded deep in nature. Then, we use these microscopic gems to produce herbal medicines that are extraordinarily safe and effective.
Dexa: A Snapshot
Employees
Patents
Trademarks
Pharmacies Covered Directly
International Alliances
Marketing Authorisations
Latest News
12 September 2022
Synergy of Dexa Group, National Population, and Family Planning Agency, and Indonesian Midwives Association to Pursue a 14% Reduction of Stunting in 2024
According to the Indonesian Toddler Nutrition Status Survey (SSGBI), the incidence of stunting in Indonesia remains at 24.4%, much behind the 14% objective set by the 2020-2024 National Medium-Term Development Plan (RPJMN). For that purpose, Dexa Group cooperated with the National Population and Family Planning Agency (BKKBN) to host a…
1 September 2022
More Than 17 Years Trusted by Indonesian Families, STIMUNO Wins Indonesian Mom's Favorite Brand Choice Awards 2022
For more than 17 years, STIMUNO, the first phytopharmaca immunomodulator in Indonesia, had been relied on by the Indonesian Family to support the health of their immune systems. For this accomplishment, STIMUNO earned the Top 5 Indonesian Mom's Favorite Brands for Multivitamin Category in the Household & Personal Care (non-food)…
26 August 2022
Supporting Making Indonesia 4.0, Dexa Group Through Ferron Par Pharmaceuticals Accelerates The Implementation of Industry 4.0
Indonesia's Ministry of Industry accelerates seven industrial sectors, including pharmaceuticals, in implementing the Making Indonesia 4.0 roadmap to make Indonesia the top 10 big countries with the most robust economy globally by 2030. In line with this effort, as Indonesia's leading international pharmaceutical company, Dexa Group has implemented industry 4.0…
24 August 2022
Dexa Group Consistently Maintains Natural Ingredient Quality for Indonesian Phytopharmaceutical Products
Dexa Group, as a national pharmaceutical company, is committed to meeting the quality of Indonesian natural raw materials as the content of Indonesian Indigenous Modern Medicines, beginning with cultivation, harvesting, and post-harvest processes and continuing through the manufacturing process by Good Traditional Medicine Manufacturing standards (CPOTB). This is necessary to…
12 August 2022
The Ministry of Health Continues to Encourage the Use of Phytopharmaceuticals in Health Service Facilities
The government primarily focuses on developing phytopharmaceuticals to create a system of health resilience and domestic pharmaceutical self-reliance. Launching the Phytopharmaca Formulary and promoting its usage in medical institutions are examples of the government's commitment to fostering the use of phytopharmaceuticals. The Director General of Pharmaceuticals and Medical Devices at…
5 August 2022
Dexa Group's Commitment to Encourage the Production of Natural Medicine Raw Materials for National Independence
With more than 28000 plant species and 2,848 medicinal plants, Indonesia has the second-highest biodiversity in the world. Its natural resources hold tremendous promise for developing phytopharmaceuticals and herbal medicines, including Indonesia Indigenous Modern Medicine (IIMM). Penny K. Lukito, head of the Food and Drug Supervisory Agency (BPOM), stated that…